Home
Scholarly Works
23: Cost-Effectiveness of Sabr in Oligometastatic...
Journal article

23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial

Authors

Qu M; Chen Y; Zaric G; Senan S; Olson R; Harrow S; John-Baptiste A; Gaede S; Mulroy L; Schellenberg D

Journal

Radiotherapy and Oncology, Vol. 163, ,

Publisher

Elsevier

Publication Date

October 1, 2021

DOI

10.1016/s0167-8140(21)08901-5

ISSN

0167-8140

Contact the Experts team